Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Atara Biotherapeutics (ATRA) Preferred Stock Liabilities (2012 - 2014)

Updated

Atara Biotherapeutics' Preferred Stock Liabilities came in at $74.57 million for Q3 2014.

Analysis

Atara Biotherapeutics (ATRA) Preferred Stock Liabilities (2012 - 2014) Analysis & Trends

At the end of FY2013, Atara Biotherapeutics' Preferred Stock Liabilities was $61.09 million.

  • Going back by year, Preferred Stock Liabilities was $4.95 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Atara Biotherapeutics 124.14 Mn 114.24 Mn 959,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 74.57 Mn
Dec 31, 2013 61.09 Mn
Dec 31, 2012 4.95 Mn
API Access

Atara Biotherapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ATRA&period=max&api_key=YOUR_API_KEY